乳腺癌软脑膜转移的诊断及治疗进展OA
Advances in diagnosis and treatment of leptomeningeal metastases from breast cancer
在乳腺癌中,软脑膜转移的发生率虽很低,但患者临床症状通常较重、生存期较短.目前,软脑膜转移的诊断主要依靠脑及脊髓核磁共振成像或脑脊液细胞学检查,但二者的敏感度有限,从而导致诊断的延后,进而影响治疗.同时,由于血脑屏障的存在,可用于软脑膜转移治疗的药物有限,而局部治疗,如鞘内注射及放疗的效果也存在争议.该文就乳腺癌软脑膜转移的诊断及治疗进展进行系统阐述,以期对临床实践提供参考.
Leptomeningeal metastases(LM)in breast cancer patients are rare,but are usually accompanied by severe symptoms and a very poor prognosis.So far,MRI of the brain and/or spinal cord and cytological examination of cerebrospinal fluid(CSF)are the two primary methods used to diagnose LM.However,the sensitivity of either technique is limited,leading to a long diagnostic process,and delaying treatment.Traditional chemotherapy and targeted therapies used to treat systemic diseases are hampered by the blood-brain barrier.Similarly,the efficacy of intrathecal therapy and radiotherapy is controversial.This review summarized advances in the diagnosis and therapies of LM in breast cancer,in the hopes of providing a reference for clinical practice.
董晓培;张少华
解放军总医院肿瘤医学部,北京 100071解放军总医院肿瘤医学部,北京 100071||安徽医科大学,合肥 230031
医药卫生
乳腺肿瘤软脑膜转移诊断治疗进展
breast neoplasmsleptomeningeal metastasesdiagnosistherapeutic progress
《军事医学》 2026 (1)
70-77,8
评论